[{"AccountsPayableCurrent_0_Q2_USD":10132000.0,"OperatingLeaseLiability_0_Q2_USD":41294000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3966000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":37328000.0,"OperatingLeasePayments_2_Q2_USD":3400000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":68304000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.062,"OperatingLeaseCost_2_Q2_USD":5385000.0,"OtherAssetsNoncurrent_0_Q2_USD":14903000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-3441000.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_1_Q2_USD":-1308000.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_2_Q2_USD":3441000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":9000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-35000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":7425000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":1308000.0,"OperatingLeaseCost_1_Q2_USD":2697000.0,"OperatingIncomeLoss_2_Q2_USD":-95002000.0,"OperatingIncomeLoss_1_Q2_USD":-48700000.0,"Liabilities_0_Q2_USD":389906000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":835363000.0,"LiabilitiesCurrent_0_Q2_USD":136943000.0,"MinorityInterest_0_Q2_USD":0.0,"MinorityInterestDecreaseFromRedemptions_2_Q2_USD":943000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":25254000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":134588000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-121117000.0,"NetIncomeLoss_1_Q2_USD":-47169000.0,"NetIncomeLoss_2_Q2_USD":-93102000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":-5000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":-11000.0,"NoncontrollingInterestIncreaseFromBusinessCombination_2_Q2_USD":64000.0,"OperatingExpenses_1_Q2_USD":76572000.0,"OperatingExpenses_2_Q2_USD":149154000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_2_Q2_USD":0.0,"LettersOfCreditOutstandingAmount_0_Q2_USD":1500000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_2_Q2_USD":0.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":2725000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":1364000.0,"ShareBasedCompensation_2_Q2_USD":17007000.0,"StockholdersEquity_0_Q2_USD":445457000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":445457000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":2054000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2_Q2_USD":2054000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":54152000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":24732000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":1393000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_2_Q2_USD":977000.0,"VariableLeaseCost_1_Q2_USD":614000.0,"VariableLeaseCost_2_Q2_USD":1326000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":143550000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":143984000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":9081000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":27872000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-871083000.0,"RestrictedCashNoncurrent_0_Q2_USD":1500000.0,"PaymentsToAcquireAdditionalInterestInSubsidiaries_2_Q2_USD":119000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":180049000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":15213000.0,"PreferredStockValue_0_Q2_USD":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":16722000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":2054000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":3702000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_2_Q2_USD":323099000.0,"ProceedsFromSaleOfHeldToMaturitySecurities_2_Q2_USD":6870000.0,"ProfitLoss_2_Q2_USD":-93113000.0,"ProfitLoss_1_Q2_USD":-47174000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":49588000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":60086000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":116520000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":1500000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_1_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":10331000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":2938000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":7094000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":359775000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":49205000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":2267000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":169878000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":171378000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":38549000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":408980000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-45896000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-96534000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q2_USD":-5000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_Q2_USD":-11000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":-45901000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":-96545000.0,"CommonStockValue_0_Q2_USD":1451000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q2_USD":359775000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0_Q2_USD":49205000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":408922000.0,"AccountsReceivableNetCurrent_0_Q2_USD":6882000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-1733000.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":17406000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":15448000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":1987000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1313102000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":9483000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":17007000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":9483000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":17007000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":16978884.0,"Assets_0_Q2_USD":835363000.0,"AssetsCurrent_0_Q2_USD":554064000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":84000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":26000.0,"ContractualObligation_0_Q2_USD":14092000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":93957000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":201251000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded_1_Q2_USD":0.0,"IncreaseDecreaseInAccruedInterestReceivableNet_2_Q2_USD":-228000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-41481000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":-3253000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":998000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":4441000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":56298000.0,"InterestAndOtherIncome_1_Q2_USD":1550000.0,"InterestAndOtherIncome_2_Q2_USD":2176000.0,"InterestReceivableCurrent_0_Q2_USD":807000.0,"LeaseCost_1_Q2_USD":3311000.0,"LeaseCost_2_Q2_USD":6711000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":51625000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":6995000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":7312000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":7242000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":1658000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":143550000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-3204000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":24000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded_2_Q2_USD":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":6959000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":4120000.0,"EarningsPerShareBasic_1_Q2_USD":-0.33,"EarningsPerShareBasic_2_Q2_USD":-0.65,"EarningsPerShareDiluted_1_Q2_USD":-0.33,"EarningsPerShareDiluted_2_Q2_USD":-0.65,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-176000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":16486000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":32634000.0,"Goodwill_0_Q2_USD":41501000.0,"GoodwillAndIntangibleAssetImpairment_2_Q2_USD":0.0,"ImpairmentOfLongLivedAssetsHeldForUse_2_Q2_USD":0.0,"IncomeLossIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":-47150000.0,"IncomeLossIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":-92826000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":287000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":143984000.0,"Ticker":"SGMO","CIK":"1001233","name":"SANGAMO THERAPEUTICS, INC","OfficialName":"Sangamo Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"750923571.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]